rhesus macaques 发生代谢综合征,可逆性血管功能障碍会对皮奥格利塔产生反应
Xiuqin Zhang1, Rongli Zhang, Susanne Raab
1Institute of Molecular Medicine, Peking University, No.5 Yiheyuan Rd, Haidian District, Beijing 100871, China.
Circulation
|June 22, 2011
概括
代谢综合征 (MetS) 的组成部分跟踪在一起,将代谢和心血管问题联系起来. 皮奥格利塔治疗逆转了血管功能障碍,支持共享机制和早期干预MetS.
科学领域:
- 代谢和心血管研究.
- 人类疾病的灵长类模型.
- 药理干预措施 药理干预
背景情况:
- 代谢综合征 (MetS) 是一组疾病,包括肥胖,高血压,失脂症和胰岛素抵抗.
- 关于MetS的潜在病理生理学,无论是共享的机制还是巧合的风险因素,仍在争论中.
研究的目的:
- 为了研究代谢和心血管组件在MetS发育过程中的共同出现.
- 探索MetS和血管功能障碍之间的机械联系.
- 评估pioglitazone在MetS中的治疗潜力.
主要方法:
- 在18个月内识别和监测有MetS倾向的 rhesus.
- 评估代谢和心血管参数,包括流媒体扩张.
- 用PIARγ激动剂pioglitazone治疗MetS动物.
主要成果:
- 在 rhesus 的疾病进展过程中,MetS 组件一起跟踪.
- MetS与流媒体扩张的显著损害有关,这表明血管功能障碍.
- 皮奥格利塔治疗改善了脂质不良和胰岛素抵抗,完全恢复了血管功能.
结论:
- 共享的病理生理机制是MetS发展和心血管并发症的基础.
- 针对MetS组件的早期干预是有益的.
- 非人类灵长类动物模型对MetS研究和翻译研究有价值.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


